[1] AhmadiA,MobasheriM,Hashemi-NazariSS,BaradaranA,ChoobiniZM, 2014.Prevalence of hypertension and type 2 diabetes mellitus in patients with colorectal cancer and their median survival time: A cohort study,J Res Med Sci 19 850 -4
[2] 2014.Diagnosis and classification of diabetes mellitus,Diabetes care 37 S81 -90
[3] NakagomiA,SaikiY,KosugiM,KohashiK,YoshikawaY,YamaneY, 2013.Effect of insulin resistance associated with compensatory hyperinsulinemia on the long-term prognosis in patients with vasospastic angina,Int J Cardiol 167 2222 -27
[4] ParkSE,RheeEJ,ParkCY,OhKW,ParkSW,KimSW, 2013.Impact of hyperinsulinemia on the development of hypertension in normotensive, nondiabetic adults: a 4-year follow-up study,Metabolism 62 532 -8
[5] LookAHEAD, 2010.Research Group. Long term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes: Four year results of the Look AHEAD trial,Arch Intern Med 170 1566 -
[6] KalupahanaNS,MoustaidMoussa N., 2012.The renin angiotensin system: A link between obesity, inflammation and insulin resistance,Obes Rev 13 136 -49
[7] ManriqueC,LastraG,GardnerM,SowersJR, 2009.The renin angiotensin aldosterone system in hypertension: Roles of insulin resistance and oxidative stress,Med Clin North Am 93 569 -82
[8] IwaiM,KannoH,TomonoY,InabaS,SenbaI,FurunoM, 2010.Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-Ay mice,J Hypertens 28 1471 -81
[9] AtlasSA, 2007.The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition,J Manag Care Pharm 13 9 -20
[10] CampbellDJ, 2009.Renin inhibitors - Mechanisms of action,Aust Prescr 32 132 -5
[11] IwaiM,KannoH,TomonoY,InabaS,SenbaI,FurunoM, 2010.Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-Ay mice,J Hypertens 28 1471 -81
[12] LastraG,HabibiJ,Whaley-ConnellAT,ManriqueC,HaydenMR,RehmerJ, 2009.Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression,Endocrinology 150 2561 -8
[13] WahliW, 2012.PPARs at the crossroads of lipid signaling and inflammation,Trends Endocrinol Metab 23 351 -63
[14] MiyazakiY,De Fronzo RA, 2008.Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients,Diabetes Obes Metab 10 1204 -11
[15] ZhangM,LvXY,LiJ,XuZG,ChenL, 2008.The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model,Exp Diabetes Res 704045 -
[16] GilbertER,FuZ,LiuD., 2011.Development of a nongenetic mouse model of type 2 diabetes,Exp Diabetes Res 416254 -
[17] SrinivasanK,ViswanadB,AsratL,KaulCL,RamaraoP, 2005.Combination of high-fat diet-fed and low-dose streptozotocintreated rat: A model for type 2 diabetes and pharmacological screening,Pharmacol Res 52 313 -20
[18] MoritohY,TakeuchiK,AsakawaT,KataokaO,OdakaH.,Combining, 2009.a dipeptidyl peptidase 4 inhibitor, alogliptin, with pioglitazone improves glycaemic control, lipid profiles and β cell function in db/db mice,Br J Pharmacol 157 415 -26
[19] DongYF,LiuL,KataokaK,NakamuraT,FukudaM,TokutomiY, 2010.Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes,Diabetologia 53 180 -
[20] HabibiJ,Whaley-ConnellA,HaydenMR,De-MarcoVG,SchneiderR,SowersSD, 2008.Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren 2 rat,Endocrinology 149 5643 -53
[21] ChakravartyS,KalitaJC, 2012.Antihyperglycaemic effect of flower of Phlogacanthus thyrsiflorus Nees on streptozotocin induced diabetic mice,Asian Pac J Trop Biomed 2 S1357 -61
[22] CollinoM,AragnoM,CastigliaS,MiglioG,TomasinelliC,BoccuzziG, 2010.Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation,Br J Pharmacol 160 1892 -902
[23] AndrikopoulosS,BlairAR,DelucaN,FamBC,ProiettoJ, 2008.Evaluating the glucose tolerance test in mice,Am J Physiol Endocrinol Metab 295 E1323 -32
[24] CookseyRC,JonesD,GabrielsenS,HuangJ,SimcoxJA,LuoB,−, 2010.Dietary iron restriction or iron chelation protects from diabetes and loss of β-cell function in the obese (ob/ob lep,Am J Physiol Endocrinol Metab 298 E1236 -43
[25] BrayMS,TsaiJY,Villegas-MontoyaC,BolandBB,BlasierZ,EgbejimiO, 2010.Time of day dependent dietary fat consumption influences multiple cardiometabolic syndrome parameters in mice,Int J Obes 34 1589 -98
[26] ChouCL,LaiYH,LinTY,LeeTJ,FangTC, .Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats,Arch Med Sci 201 882 -
[27] DongYF,LiuL,KataokaK,NakamuraT,FukudaM,TokutomiY, 2010.Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes,Diabetologia 53 180 -
[28] ChengQ,BoucherBJ,LeungPS, 2013.Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin-angiotensin system in mice,Diabetologia 56 553 -62